Voices
Hiba Narvel: Prostate Cancer Biomarkers with a Focus on Galectin-3
Hiba Narvel/X

Hiba Narvel: Prostate Cancer Biomarkers with a Focus on Galectin-3

Hiba Narvel, Medical Oncology and Hematology fellow at ASCO, shared a post on X:

“Our prospective prostate cancer trial has officially finished accrual!

This investigation targets Galectin-3, a multi-functional protein critical to how cancer cells adhere, migrate, and escape the immune system in the metastatic niche.”

Hiba Narvel

Title:Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications

Authors: Hiba Narvel, Mohammad Arfat Ganiyani, Adnan Gulam Nabi, Aman Goyal , Rohan Garje, Sanjay Srinivasan, Hafiz Ahmed,  Deepak Kilari

Read the full article on MDPI.
Hiba Narvel: Prostate Cancer Biomarkers with a Focus on Galectin-3

Other articles about prostate cancer on OncoDaily.

Adnan Gulam Nabi Aman Goyal cancer Deepak Kilari Hafiz Ahmed Hiba Narvel Mohammad Arfat Ganiyani OncoDaily Oncology Rohan Garje Sanjay Srinivasan